TARGIS (T3) SYSTEM

System, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy

FDA Premarket Approval P970008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the t3(r) targeted transurethral thermoablation system: model 4000. This device is indicated to relieve symptoms associated with benign prostatic hyperplasia (bph) and is indicated for men with prostatic lengths of 30 to 50 millimeters.

DeviceTARGIS (T3) SYSTEM
Classification NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
Generic NameSystem, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy
ApplicantUrologix, LLC
Date Received1997-02-24
Decision Date1997-08-22
Notice Date1997-11-20
PMAP970008
SupplementS
Product CodeMEQ
Docket Number97M-0457
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Urologix, LLC 14405 21st Avenue N. minneapolis, MN 55447-2000
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P970008Original Filing
S065 2015-09-10 Normal 180 Day Track No User Fee
S064 2015-06-23 Real-time Process
S063 2013-02-08 30-day Notice
S062 2012-12-10 30-day Notice
S061 2012-02-13 30-day Notice
S060 2011-12-20 Real-time Process
S059 2011-09-28 30-day Notice
S058 2011-07-01 Normal 180 Day Track
S057
S056 2011-04-04 30-day Notice
S055 2011-02-03 30-day Notice
S054
S053 2010-11-16 Real-time Process
S052 2010-07-02 Real-time Process
S051 2010-07-02 30-day Notice
S050 2010-03-19 30-day Notice
S049 2010-03-17 Real-time Process
S048 2010-03-03 Real-time Process
S047 2010-03-02 30-day Notice
S046 2009-09-23 30-day Notice
S045 2009-07-14 Real-time Process
S044 2009-06-02 30-day Notice
S043 2009-02-03 30-day Notice
S042 2008-12-30 30-day Notice
S041 2008-11-17 30-day Notice
S040 2008-10-10 30-day Notice
S039 2008-03-24 30-day Notice
S038 2008-03-10 Normal 180 Day Track
S037 2008-02-11 Real-time Process
S036 2008-01-31 Real-time Process
S035 2008-01-09 Real-time Process
S034 2007-10-17 Normal 180 Day Track
S033 2007-07-11 Normal 180 Day Track No User Fee
S032
S031 2007-02-20 30-day Notice
S030 2005-11-21 Normal 180 Day Track
S029 2005-05-10 Normal 180 Day Track
S028 2005-04-28 Real-time Process
S027 2005-04-07 Real-time Process
S026 2005-02-25 Normal 180 Day Track
S025 2005-02-01 Real-time Process
S024 2004-09-30 Normal 180 Day Track
S023 2003-01-09 Normal 180 Day Track
S022 2002-07-05 30-day Notice
S021 2002-06-21 Normal 180 Day Track
S020 2002-03-29 Real-time Process
S019 2002-02-04 Normal 180 Day Track
S018 2001-12-03 Normal 180 Day Track
S017 2001-05-24 Real-time Process
S016 2001-02-21 Normal 180 Day Track
S015 2000-11-22 Normal 180 Day Track
S014 2000-01-19 Normal 180 Day Track
S013 1999-12-16 Normal 180 Day Track
S012 1999-06-25 Normal 180 Day Track
S011 1999-02-16 Normal 180 Day Track
S010 1999-02-16 Real-time Process
S009 1998-10-21 Real-time Process
S008 1998-07-09 Real-time Process
S007 1998-06-30 Real-time Process
S006 1998-05-05 Normal 180 Day Track
S005 1998-02-12 Real-time Process
S004 1997-11-21 Real-time Process
S003 1997-10-22 Real-time Process
S002 1997-09-05 Normal 180 Day Track
S001 1997-08-26 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.